Persistence of subcutaneous infliximab after two years of the switch from intravenous infliximab to subcutaneous infliximab in Inflammatory Bowel Disease patients

被引：0
作者：
Huguet, J. M. [1 ]
Iborra, M. [2 ]
Marti, L. [3 ]
Bosca-Watts, M. M. [4 ]
Ramirez, J. J. [5 ]
Ruiz, L. [1 ]
Sanchis, L. [6 ]
Garrido, A. [2 ]
Alemany, G. [3 ]
Suria, C. [4 ]
Paredes, J. M. [7 ]
机构：
[1] Hosp Gen Univ Valencia, Gastroenterol, Valencia, Spain
[2] Hosp Univ & Politecn Fe Valencia, Gastroenterol, Valencia, Spain
[3] Hosp Francesc Borja Gandia, Gastroenterol, Valencia, Spain
[4] Hosp Clin Univ Valencia, Gastroenterol, Valencia, Spain
[5] Hosp Lluis Alcanyis Xativa, Gastroenterol, Valencia, Spain
[6] Hosp Sagunto, Gastroenterol, Valencia, Spain
[7] Hosp Univ Dr Peset Valencia, Gastroenterol, Valencia, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P657
引用
收藏
页码：I1242 / I1242
页数：1
相关论文
共 50 条
  • [31] Persistence of subcutaneous infliximab after switching from intravenous in a French national cohort of IBD patients in remission
    Mathieu, N.
    Riviere, P.
    Heluwaert, F.
    Hebuterne, X.
    Chupin, A.
    Bouguen, G.
    Vuitton, L.
    Allez, M.
    Montuclard, C.
    Nachury, M.
    Nancey, S.
    Amelie, B.
    Gilletta, C.
    Abitbol, V.
    Altwegg, R.
    De Maissin, A.
    Plastaras, L.
    Soune, P. Ah
    Boureille, A.
    Bouhnik, Y.
    Seksik, P.
    Chanteloup, E.
    Marion, S.
    Uzzan, M.
    Andrau, P.
    Rouillon, C.
    Arondel, Y.
    Biroulet, L. Peyrin
    Laharie, D.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 533 - 534
  • [32] Switching from intravenous to subcutaneous infliximab in patients with hidradenitis suppurativa
    Luque, Mar
    Barboza, Lorenza
    Sandoval, Alejandra
    Fuertes, Irene
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 145 - 145
  • [33] Effectiveness of switching to subcutaneous infliximab in inflammatory bowel disease patients with inadequate biochemical response during intravenous administration
    Lee, Bokyeong
    Kim, Minjee
    Kim, Eun Ran
    Hong, Sung Noh
    Chang, Dong Kyung
    Kim, Young-Ho
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [34] Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (02) : 369 - 370
  • [35] Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
    Bae, J. H.
    Park, J. B.
    Baek, J. E.
    Hong, S. W.
    Park, S. H.
    Yang, D. H.
    Ye, B. D.
    Byeon, J. S.
    Myung, S. J.
    Yang, S. K.
    Hwang, S. W.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1131 - I1133
  • [36] Treatment persistence, clinical, and biological outcomes following an elective switch from intravenous to subcutaneous infliximab and vedolizumab
    Outtier, A.
    Hoffert, Y.
    De Dycker, E.
    Geens, P.
    Lambrechts, T.
    Loddewijkx, E.
    Paps, A.
    Verstockt, B.
    Sabino, J.
    Vermeire, S.
    Ferrante, M.
    TARGID
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1434 - i1435
  • [37] P1008 Subcutaneous infliximab in IBD patients previously treated with an optimized intravenous infliximab dosing schedule: preliminary results on expectations and satisfaction of switching from intravenous to subcutaneous infliximab
    Moens, A.
    Holvoet, T.
    Bossuyt, P.
    Lobaton, T.
    Posen, A.
    Cremer, A.
    Capirchio, L.
    Caenepeel, C.
    Lambrecht, G.
    Amezaga, A. J.
    Reenaers, C.
    Peeters, H.
    Willandt, B.
    Deprez, N.
    De Rechter, J.
    Arijs, I
    Straetemans, N.
    Dreesen, E.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1869 - i1870
  • [38] Effectiveness of Switching to Subcutaneous Infliximab in Inflammatory Bowel Disease Patients with Inadequate Biochemical Response during Intravenous Administration
    Kim, M.
    Lee, B.
    Kim, E. R.
    Hong, S. N.
    Chang, D. K.
    Kim, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1443 - i1444
  • [39] Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
    Bae, June Hwa
    Park, Jung-Bin
    Baek, Ji Eun
    Hong, Seung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Hwang, Sung Wook
    GUT AND LIVER, 2024, 18 (04) : 667 - 676
  • [40] Switch from intravenous to subcutaneous maintenance infliximab in real world IBD cohort
    Mcgrory, L.
    Goess, C.
    Lynch, K.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 741 - 743
12345